ERBB2 and neoplasm: However, these dual CAR-T cells only eliminated ERBB2+ tumor cells, and produced modest IL-2 in response to co-stimulation with a second antigen when compared to a control CAR-T cells expressing CD28 and CD3ζ endodomain [75].